Plain-English translation of NCT07293715 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether a slightly more relaxed blood sugar target during labor is safe for pregnant people with type 1 diabetes who use hybrid closed-loop pumps. Right now, doctors aim for very tight blood sugar control (70–110 mg/dL) during labor, but researchers want to see if a wider target range (70–140 mg/dL) works just as well without harming the newborn. The study will compare babies' blood sugar levels in the first few hours after birth between the two approaches.
Most pregnant people with type 1 diabetes use newer pump technology that automatically adjusts delivery, but we don't have much research on the best blood sugar targets for this specific group during labor. Doctors need better evidence to decide whether they can safely relax blood sugar targets during labor, which might make labor management easier while keeping both parent and baby safe.
You likely qualify if…
You likely don't qualify if…
When you arrive at the hospital in labor, you will be randomly assigned to one of two blood sugar target groups. One group will aim for blood sugar between 70–140 mg/dL during labor (the wider range), while the other group will aim for 70–110 mg/dL (the tighter range), which is the current standard. Your pump and continuous glucose monitor will help manage your blood sugar, and your baby's blood sugar will be measured in the first two hours after birth to see if there are any differences between the two approaches.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States